23G微创玻璃体切割术治疗Valsalva视网膜病变  

Valsalva retinopathy treated by 23G vitrectomy

作　　者：吴敏[1] 罗哲文[1] 肖丽波[1] 薛黎萍[1] 

机构地区：[1]云南省第二人民医院眼科,云南昆明650021

出　　处：《中国实用眼科杂志》2012年第8期1004-1005,共2页Chinese Journal of Practical Ophthalmology

基　　金：云南省教育厅科学研究基金（2011C079）

摘　　要：目的探讨23G微创玻切手术对Valsalva视网膜病变的临床效果。方法回顾性分析了2007年3月至2010年3月在眼科就诊的10例（10只眼）Valsalva视网膜病变病例，经过1月保守治疗无效后接受23G微创玻璃体切割手术联合内界膜剥除，分析术后的治疗效果。结果术后1周患者最佳矫正视力BCVA0．3～0．5者7例，0．6—0．8者3例。最后一次随访时BCVA在0．6～0．8者9例，1．0者1例。除3例患者术后出现少量结膜下出血外未见其他并发症。结论23G微创玻璃体切割手术联合ILM剥除对于保守治疗无效、范围较大的黄斑区ILM下积血为主要表现的Valsalva视网膜病变，是安全有效的。Objective To discuss the clinical effect of 23G vitrectomy in treating Valsalva retinopathy. Methods Ten cases of Valsalva retinopathy were analyzed retrospectively. Those cases were treated by 23G vitrectomy from March 2007 to March 2010 after conservative treatment was failed. The post-operative outcomes were analyzed. Results One week after the surgery, BCVA in 7 cases was improved to 0.3-0.5 and it was improved to 0.6-0.8 in 3 cases. In the last follow-up, BCVA was improved to 0.6-0.8 in 9 cases and 1.0 in one case. Except mild subconjunctival hemmorrhage occurred in 3 cases, no other complications were observed. Conclusions 23G vitrectomy combined with ILM peeling is safe and effective for Valsalva retinopathy with large scale of macular sub-ILM hemorrhage which failed to response to conservative treatment.

关 键 词：VALSALVA视网膜病变 23G玻切手术 内界膜剥除 

分 类 号：R779.6[医药卫生—眼科]